Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Safety, tolerability, pharmacokinetics, and pharmacodynamics of a novel kappa opioid receptor agonist ZYKR1: a randomized double-blind placebo-control phase 1 study in healthy adult human participants.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: June 29, 2023
A Food-Effect Study to Evaluate the Oral Bioavailability of Desidustat.
Journal: Clinical pharmacology in drug development
Published: August 09, 2022
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Oral NLRP3 Inflammasome Inhibitor ZYIL1: First-in-Human Phase 1 Studies (Single Ascending Dose and Multiple Ascending Dose).
Journal: Clinical pharmacology in drug development
Published: July 21, 2022
Effect of saroglitazar 2 mg and 4 mg on glycemic control, lipid profile and cardiovascular disease risk in patients with type 2 diabetes mellitus: a 56-week, randomized, double blind, phase 3 study (PRESS XII study).
Journal: Cardiovascular diabetology
Published: March 18, 2020
Phase I Clinical Study of ZYAN1, A Novel Prolyl-Hydroxylase (PHD) Inhibitor to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Oral Administration in Healthy Volunteers.
Journal: Clinical pharmacokinetics
Published: May 17, 2017
Axillary node metastasis from primary ovarian carcinoma.
Journal: Journal of cytology
Published: March 07, 2015
Serotonin syndrome in patients with peripheral neuropathy: a diagnostic challenge.
Journal: General hospital psychiatry
Published: January 21, 2014
Showing 1-7 of 7
Last Updated: 09/26/2026